NPCE 9.70 ▲ 3.63% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroPace Inc.

    NASDAQ: NPCE · Real-Time Price · USD
    9.70
    0.34 (3.63%)
    At close: Sep 04, 2025, 3:04 PM
    3.63%
    Bid 6.9
    Market Cap 320.73M
    Revenue (ttm) 88.57M
    Net Income (ttm) -17.29M
    EPS (ttm) -0.82
    PE Ratio (ttm) -11.82
    Forward PE -13.44
    Analyst Buy
    Ask 11.9
    Volume 135,487
    Avg. Volume (20D) 274,098
    Open 9.37
    Previous Close 9.36
    Day's Range 9.27 - 9.77
    52-Week Range 5.45 - 18.98
    Beta 1.90

    About NPCE

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol NPCE
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for NPCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    NeuroPace Inc. is scheduled to release its earnings on Nov 11, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    3 months ago
    -28.39%
    Neuropace shares are trading lower after the compa... Unlock content with Pro Subscription
    3 months ago
    +20.46%
    Neuropace shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.
    news image

    3 weeks ago · seekingalpha.com

    NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript

    NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Joel D. Becker - CEO, President & Director Patrick F.

    news image

    3 weeks ago · zacks.com

    NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

    NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.26 per share a year ago.

    news image

    2 months ago · businesswire.com

    NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm

    LOS ANGELES--(BUSINESS WIRE)---- $NPCE--NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm.

    news image

    2 months ago · accessnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

    NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:NPCE). Such investors are a...

    news image

    2 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect

    NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

    news image

    2 months ago · accessnewswire.com

    Potential Securities Fraud: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE)

    NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

    news image

    2 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

    news image

    2 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

    news image

    2 months ago · accessnewswire.com

    Fraud Investigation: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) on Behalf of Shareholders

    NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

    news image

    2 months ago · accessnewswire.com

    NPCE ALERT: Ongoing Investigation Into NeuroPace, Inc. - Contact Levi & Korsinsky

    NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

    Add to Watchlist